Back
VanEck Digital Transformation ETF Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
55
DAPP
VanEck Digital Transformation ETF
Last Price:
$19.42
Seasonality Move:
-7.71%
Buy
90
KYMR
Kymera Therapeutics, Inc.
Last Price:
$94.38
Seasonality Move:
7.7%
Buy
55
VanEck Digital Transformation ETF (DAPP)
is a Buy
Is VanEck Digital Transformation ETF a Buy, Sell or Hold?
-
The current VanEck Digital Transformation ETF [DAPP] share price is $19.46. The Score for DAPP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
DAPP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
DAPP Stock Price Chart
What is VanEck Digital Transformation ETF's stock price today?
-
The VanEck Digital Transformation ETF share price today is $19.46The current trend is relatively stagnant and DAPP is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $94.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
DAPP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 49.23 | Sell |
| Chaikin Money Flow: | 204645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.02 - 21.64) | Buy |
| Bollinger Bands (100): | (17.01 - 23.15) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 86.88 | Buy |
| Chaikin Money Flow: | -462379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.8 - 71.72) | Buy |
| Bollinger Bands (100): | (43.38 - 63.26) | Buy |
DAPP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.98 | Buy |
| 20-day SMA: | 18.4 | Buy |
| 50-day SMA: | 21.84 | Sell |
| 200-day SMA: | 16.32 | Buy |
| 8-day EMA: | 18.91 | Buy |
| 20-day EMA: | 19.21 | Buy |
| 50-day EMA: | 20.21 | Sell |
| 200-day EMA: | 17.8 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70 | Buy |
| 20-day SMA: | 66.61 | Buy |
| 50-day SMA: | 61.97 | Buy |
| 200-day SMA: | 44.25 | Buy |
| 8-day EMA: | 72.36 | Buy |
| 20-day EMA: | 67.57 | Buy |
| 50-day EMA: | 61.93 | Buy |
| 200-day EMA: | 49.42 | Buy |
VanEck Digital Transformation ETF Earnings Growth & DAPP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
VanEck Digital Transformation ETF Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||